BIT 0.00% 2.5¢ biotron limited

News: Biotron's Hep C drug candidate phase 2a tri, page-9

  1. J8
    14,567 Posts.
    lightbulb Created with Sketch. 830
    re: News: Biotron's Hep C drug candidate phas... Correct Giddyup ,

    It's being capped by the option sellers ATM .

    It wont last long though , the product is too good .

    Easier to accumulate at these bargain prices that way .

    Broker reports suggested a 35c target on success with the HCV trial ........... perhaps by Xmas when the full results are available .

    Looking quite strong really .

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.